Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 3 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Recs

0
Player Avatar gravmic (< 20) Submitted: 5/16/2011 3:35:28 PM : Outperform Start Price: $8.06 RIGL Score: -5.93

magic formula

Featured Broker Partners


Advertisement